CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY
|
|
|
- Willis Parrish
- 10 years ago
- Views:
Transcription
1 CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY
2 Immunological Implications of Peptide-Carbohydrate Mimicry 8.1 Introduction The two chemically dissimilar molecules, a peptide (12mer) and a carbohydrate moiety (methyl a-d-mannopyranoside), sharing a common receptor, Concanavalin A, were earlier shown to exhibit molecular mimicry. The polyclonal antibodies raised against sugar show crossreactivity with peptide and its various analogs and the antibodies against the peptide crossreact with sugar (Kaur et al., 1997). The mimicry between peptide and carbohydrate ligands was further probed at the structural level, which is extensively described in earlier chapters. Here, we have further attempted to asses the functional mimicry between peptide and sugar as a function of progression of the immune response so as to understand the course of maturation of the mimicry and also to comprehend various factors affecting it. 8.2 Results Tile Mimicry Analyzed at Different Levels of Antibody Response Earlier experiments have indicated that immunization of Balb/c mice with peptide or sugar conjugate elicits crossreacting antibodies (Kaur et a/., 1997). It was important to examine the issues related to the extent of crossreadivity at different time points during the course of maturation of the antibody response. We have analyzed the induction and subsequent progression of the mimicry at different levels of antibody maturation JgM Response Two separate groups of female Balb/c mice were immunized with Single dose (1fl9 protein/mouse) of sugar and peptide conjugated to BSA (bovine serum 14
3 l_'-- ~ Sugar binding Peptide binding.4 E c CJ) -.::t Ctl Control Anti Anti sugarab peptideab Figure 8.1: Analysis of mimicry at IgM level. The polyclonal antisugar antibody response at IgM level is dominated by crossreacting antibodies. The control for crossreactivity is shown.
4 Immunological Implications of Peptide-Carbohydrate Mimicry albumin), respectively. The serum was collected at regular intervals, starting as early as day5. The serum was tested for IgM specificity against the DT (diphtheria toxoid) conjugated immunogen. The early primary response generated against the antigen could be detected within a week after immunization and reaches a peak at day14. Thus all the subsequent analysis for IgM was done at day14 (Figure 8.1). Both sugar as well as the peptide induced IgM response, although immunogenicity varied widely in the two cases. The initial analysis revealed that anti sugar polyclonal antibody titers are very high. Moreover, almost the entire population of the antisugar antibodies generated, were capable of crossreacting with the peptide. In contrast, the antipeptide polyclonal antibodies show very low titers at IgM level. When these low titer antibodies were analyzed for crossreactivity, they showed negligible binding to sugar IgG Response The serum collected at regular intervals was also analyzed for IgG specificity. The primary IgG response reaches a peak at day28 and hence all subsequent analysis of primary IgG was done at day28. The mice were further boosted with the corresponding antigen at day42 to analyze the crossreactivity at secondary IgG level. The secondary IgG analysis has been done in all the cases at day56. As evident from Figure 8.2A, the antisugar antibodies show poor primary IgG titers. The booster at day42 enhances the antibody titer upto 1 Of old. The corresponding cross reactivity of antisugar antibodies follows a similar trend both at primary as well as the secondary IgG response. Although, the antisugar antibodies do not show any detectable crossreactivity at day28, the Signal increases Significantly after the booster (Figure 8.28). The antipeptide polyclonal antibodies on the other hand show very high titers against peptide at primary IgG level, such that it 15
5 A 2. ~ Anti Sugar pabs ~ Anti Peptide pabs E c m -.;t... as Preimmune Primary Secondary B.4 ~ Anti Sugar pabs m Anti Peptide pabs E c m -.;t... m o.olbj.-- Preimmune Primary Secondary Figure B.2: Maturation of the humoral response. [AJ IgG titers of antisugar and antipeptide pabs as a function of time. [BJ The crossreactivity of antisugar and antipeptide pabs as a function of time.
6 Immunological Implications of Peptide-Carbohydrate Mimicry reaches saturation and there is no significant increase in the antibody population after the booster (Figure 8.2A). The crossreactivity in case of antipeptide antibodies is higher than in case of antisugar antibodies at day28 and increases significantly after the booster. However, day56 antibodies against peptide and sugar show comparable crossreactivity (Figure 8.28) Competitive Studies The affinities of antisugar and antipeptide antibodies at different levels of maturation were assayed using competitive ELISA. Various peptide and sugar analogs compete with 12mer- and sugar-ot coated on the plate for binding to anti sugar and anti peptide antibodies respectively in solution. The crossreactivity of antisugar antibodies, assayed using direct binding ELISA, shows low signals at the primary response, as the antisugar antibody titers were low. But, the competition amongst various peptides for binding to antisugar antibodies indicates that affinity of these antibodies for mimicking ligands is notable even though the titers are low. The antisugar antibodies at day28 show higher crossreactivity with 1mer and 15mer and in comparison to 12mer. The same antibodies, after booster, at day56, exhibit enhanced crossreactivity with 12mer (Figure 8.3A). Similarly, the antipeptide antibodies also show crossreactivity with different sugar analogs at the primary response. The affinity of the antibodies is highest for methyl a-o-mannopyranoside and lowest for methyl a-oglucopyranoside. However, secondary IgG shows enhanced affinity for glucopyranoside and significantly lower affinity for a-lactose (Figure 8.38). 16
7 RVWYPYGSYLTASGS A OVFYPYPYASGs~IIII~i:::::::::~~ MYWYPYASGs~IIII~~~~lIlIlIii~; ~~ ~Primary ~Secondary o B % Inhibition Me a-o-mannopyranoside m~m~m~mmmm~i~i~ie;;~~ Me a-o-g/ucopyranoside ~~~~m~ml=== ~Primary ~Secondary o % Inhibition Figure 8.3: Competitive binding analysis of antisugar and antipeptide antibodies. fa] The comparison of antisugar antibody crossreactivity with various peptide analogs as a function of time. fb] The comparison of anti peptide antibody crossreactivity with various sugar analogs as a function of time.
8 Immunological Implications o/peptide-carbohydrate Mimicry Modifications in T-cell Help Prepriming To explore the role of limiting T-cell help in the process of selection of antibodies showing crossreactivity in case of antisugar antibodies, an experiment was done, where 8alb/c mice were first primed with 8SA before immunization with conjugated sugar. A booster of sugar was given at day42. The rationale here is to ensure the presence of an elevated frequency of 8SA primed Th cells at the time of antigenic challenge. Sera from such mice were collected at day28 and day56 after the first immunization, to assay primary and secondary antibody titers respectively. It was observed that the mice primed with 8SA, show better titers at primary IgG level than those, which were unprimed. As expected, the antibody titers increase after booster. On the other hand, the crossreactivity of the antibodies does not follow a similar trend. The crossreactivity of antisugar antibodies at day28 is higher than in unprimed case and reaches saturation. It shows no increase even after the booster unlike in unprimed case discussed earlier (Figure 8.4) Analysis Using the Single T-cell Epitope In order to compare the extent of crossreactivity of antibodies using promiscuous T-cell epitopes as against the protein, the 8-cell epitope was synthesized colinearly with two known T-cell epitopes to obtain peptides that would be immunogenic in mice. The T-cell epitopes chosen were those that had been previously well characteri7sd and were derived either from residue 44-6 of respiratory syntical virus (designated as RSV) (Nicholas et a/., 1989) or from residues of tetanus toxoid (designated as TT) (Ho et a/., 199). In all these cases a spacer of two glycine residues separated the 8- and T-cell epitopes 17
9 ~ Sugar binding ~ Peptide bindirg 1. E c.8 ) ~... m ~~~~:L-~~~~---I:.<~~=i4...J Prepriming BSA BSA BSA BSA BSA BSA Priming Booster Sugar Sugar Sugar Sugar Sugar Sugar Figure 8.4: Analysis of specificity and crossreactivity of antisugar pabs as a function of time on prepriming.
10 A - coaling Sug-BSA -coating 13mar-BSA E c > V -co ci cj E c 1..6 > V -co ci.5.8 cj Days Days c RSV:CEYNVFHNKTFELPRA n : PGINGKAIHLVNNESSE Figure 8.5: Analysis of antipeptide antibody crossreactivity as a function of time using promiscuous T cell epitopes. [A] RSV. [B] IT. [e] Sequence of the two T cell epitopes used.
11 Immunological Implications of Peptide-Carbohydrate Mimicry sequences. The immunization schedule followed for these antigens was same as for peptide-8sa. The analysis of the primary IgG shows that unlike in case where a carrier protein is used as a T-cell epitope, the overall titers of the antibody are low in this case, however the corresponding crossreactivity is very high (Figure 8.SA and 8). Further, the antibody titers are lower in case of IT as compared to RSV. After the antibody titers fell to basal levels by day42, a booster of the corresponding antigen was given in both the cases. SurpriSingly, after the booster, there was no significant enhancement in the antibody titers in either case showing that the antibodies reach saturation in the primary response itself. The secondary IgG antibodies formed have titers comparable to the primary response. Similarly, the crossreactivity does not show a corresponding increase in the signal. In fact, crossreactivity levets are lower than in the primary response Tile Sugar and Peptide are Immunological Mimics The crossreactivity of antibodies with a chemically different molecule as seen above reflects that the two molecules are mimicking at the topological level. In order to see if the immune system is capable of identifying these molecules as mimics, cross-immunization experiments were done. A group of female 8alb/c mice was immunized intra peritoneally with sugar conjugated to 8SA. The serum was collected at regular intervals and analyzed by ELISA for the presence of antigen specific antibodies. The immune response was further boosted by giving the sugar mimicking peptide (12mer) conjugated to 8SA as a booster at day42. The analysis of the primary IgG response shows that the antisugar antibodies reached a peak at day28. It was discovered that primary IgG levels of antisugar antibodies could be amplified on giving chemically different molecule as a booster 18
12 Priming Booster Day Sugar 28 Sugar Sugar Sugar Peptide 56 Sugar at 49 nm Figure 8.6: The IgG response against sugar can be boosted using the carbohydrate mimicking peptide.
13 Immunological Implications o/peptide-carbohydrate Mimicry (Figure 8.6). The control, group where no booster was given, shows same titers as the day28. This implies that the peptide is capable of reactivating the T-cells that have been earlier primed by the sugar and is capable of recruiting the T-cell help. 8.3 Discussion The analysis of the antisugar and antipeptide antibody specificity and crossreactivity at different time points revealed certain differences. Whereas the IgM response, in case of sugar was dominated by mimicking antibodies, the titers of antipeptide antibodies were low and no mimicry could be detected. Sugar being a small molecule and structurally simpler provides a smaller surface area of contact for the corresponding antibody and hence can be treated as a single epitope. Thus, majority of the antibody population generated against sugar would be capable of showing crossreactivity with mimicking epitope on the peptide. Peptide being a large, and structurally more complex and flexible molecule in comparison to sugar will constitute multiple epitopes and all accessible determinants on the surface of peptide will be recognized. Thus, the early IgM response in this case would be composed of antibody specificity that spanned the entire peptide and only small population of which will crossreact with the sugar. Similarly, differences were observed in the binding profiles at primary and secondary IgG level. The observed differences in IgM and primary IgG response of antisugar and antipeptide antibodies, especially in terms of mimicry could reflect the differential proliferative abilities of the corresponding epitope-specific 8 cells. The results show that the early primary humoral response against sugar is biased in favor of the mimicking epitope. Further the IgM to IgG class switch for antibodies against sugar is less efficient than in case of peptide. Competitive data suggests that in the primary response, sugar elicits low titer but high affinity antibodies capable of showing mimicry with various peptide 19
14 Immunological Implications of Peptide-Carbohydrate Mimicry analogs. However, no significant change occurs in the affinity of antibodies, eventhough the titers increase significantly after the booster. In case of antipeptide antibodies, the affinity profile against different sugars changes although the titers remain the same. The antisugar antibody response analyzed in terms of titers as well as crossreactivity at various time points by modifying the T-cell help gave interesting results. The antisugar antibody titers at primary immune response level improved on preprimimg as compared to the unprimed case. Thus, in presence of unlimited T-cell help, all the B-cell clones get activated and therefore we see increase in the mimicry signal even at primary IgG level. However, the mimicry reaches saturation at the primary response and shows no increase after the booster. Further more, use of single T-cell epitope, as against a protein carrier, influences the immune response in terms of titers. The overall signal for peptide coupled to promiscuous T-cell epitopes is lower than peptide coupled to a carrier, however the mimicry follows a reverse trend. This may be because the B-cells that are activated using the single T-cell epitope are fewer in comparison to the protein carrier. This is expected because the size of the carrier being large will activate larger numbers of B-cells as against using a single T-cell epitope. However, the numbers of clones of the B-cells that yield mimicking antibodies against the sugar are higher. In other words, the immunodominant epitope gets defined much early in the course of maturation of the immune response and hence we see higher levels of mimicry in both the cases at primary response itself. Thus, when we use a single T- cell epitope, the mimicry signal dominated in the early IgG response as the selection seems to have occurred in the primary response itself and on subsequent maturation the mimicking antibodies did not get selected. The mimicry between chemically different molecules is not just manifested in 11
15 Immunological Implications o/peptide-carbohydrate Mimicry terms of crossreactivity of polyclonal antibodies and hence is not a physical phenomenon. The antisugar antibodies could be boosted using a carbohydrate mimicking peptide on cross immunization. The two molecules are recognized as mimics even by the immune system. Thus, mimicry is also elicited in terms of reactivating the memory T-cells. To conclude, the molecular mimicry observed between the two molecules manifests in the immune response. The primary IgG response against one molecule can be enhanced using the mimic. However the maturation of the humoral response analyzed in terms of primary (lgm and IgG) and secondary (lgg) antibody titers, shows subtle differences in their and crossreactivity profiles against the two ligands. The antigenic immunodominance during maturation may be invoked to explain these differences. The matured polyclonal antibody response against any ligand need not necessarily represent a complete topological map of the antigen. Therefore, the extent of mimicry may depend on the extent of overlap between the immunodominant epitope and the mimicking epitope. It was observed that the mimicry as seen by the immune system, depends on the extent and nature of the T- cell help provided either in terms of a carrier protein or the single peptide as the T- cell epitope. Thus, the carbohydrate-peptide mimicry, which was originally defined as a static topological equivalence between two chemically distinct molecular species in terms of polyclonal antibody crossreactivity (Kaur et a/., 1997) is influenced by the kinetic immunological factors. This observation may provide important basis for analyzing mechanisms responsible for autoimmune disorders. III
KMS-Specialist & Customized Biosimilar Service
KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal
Aviva Systems Biology
Aviva Custom Antibody Service and Price Mouse Monoclonal Antibody Service Package Number Description Package Contents Time Price Customer provides antigen protein $6,174 Monoclonal package1 (From protein
Why use passive immunity?
Vaccines Active vs Passive Immunization Active is longer acting and makes memory and effector cells Passive is shorter acting, no memory and no effector cells Both can be obtained through natural processes:
Custom Polyclonal Anti-Peptide Antibody, Brochure
Custom Polyclonal Anti-Peptide Antibody, Brochure Interest in any of the products, request or order them at Bio-Connect. Bio-Connect B.V. T NL +31 (0)26 326 44 50 T BE +32 (0)2 503 03 48 Begonialaan 3a
Antigens & Antibodies II. Polyclonal antibodies vs Monoclonal antibodies
A Brief Review of Antibody Structure A Brief Review of Antibody Structure The basic antibody is a dimer of dimer (2 heavy chain-light chain pairs) composed of repeats of a single structural unit known
Chapter 18: Applications of Immunology
Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing
Advanced BioDesign Outlines Solutions. Antibody Overview. by Advanced BioDesign. Project Start. Immunogenicity. Selecting Your Antigen
Advanced BioDesign Outlines Solutions by Advanced BioDesign Antibody Overview Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, you may develop
Aviva Systems Biology
Aviva Custom Antibody Services and Prices Rabbit Polyclonal Antibody Service Package Number Description Package Contents Time Price Polyclonal package 1 (From protein to antiserum) Polyclonal package 2
Antibody Services. Best Guarantees in the Industry! Monoclonal Antibody Services. Polyclonal Antibody Services. Express Antibody TM Services
Antibody Services Best Guarantees in the Industry! Monoclonal Antibody Services Polyclonal Antibody Services Express Antibody TM Services Guaranteed Antibody Services Antibody Purification Services Your
Custom Antibodies Services. GeneCust Europe. GeneCust Europe
GeneCust Europe Laboratoire de Biotechnologie du Luxembourg S.A. 6 rue Dominique Lang L-3505 Dudelange Luxembourg Tél. : +352 27620411 Fax : +352 27620412 Email : [email protected] Web : www.genecust.com
3 months 1.5 months 1.5 months. 1 month
Rabbit monoclonal antibody (Mab) is secreted by the plasma B-cell of the rabbit. Traditional generation of rabbit Mab relies on a rabbit myeloma for B- cell fusion (
Your partner in immunology
Your partner in immunology Expertise Expertise Reactivity Reactivity Quality Quality Advice Advice Who are we? Specialist of antibody engineering Covalab is a French biotechnology company, specialised
LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES
Introduction to immunology. LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Today we will get to know: The antibodies How antibodies are produced, their classes and their maturation processes Antigen recognition
HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13
SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,
CUSTOM ANTIBODIES. Fully customised services: rat and murine monoclonals, rat and rabbit polyclonals, antibody characterisation, antigen preparation
CUSTOM ANTIBODIES Highly competitive pricing without compromising quality. Rat monoclonal antibodies for the study of gene expression and proteomics in mice and in mouse models of human diseases available.
CONTENT. Chapter 1 Review of Literature. List of figures. List of tables
Abstract Abbreviations List of figures CONTENT I-VI VII-VIII IX-XII List of tables XIII Chapter 1 Review of Literature 1. Vaccination against intracellular pathogens 1-34 1.1 Role of different immune responses
27E10: A unique monoclonal antibody against MRP8/14 (S100A8/A9, Calprotectin)
BMA BIOMEDICALS Rheinstrasse 28-32 CH-4302 Augst (Switzerland) Phone:+41 61 811 6222 Fax: +41 61 811 6006 [email protected] www.bma.ch 27E10: A unique monoclonal antibody against MRP8/14 (S100A8/A9, Calprotectin)
Basics of Immunology
Basics of Immunology 2 Basics of Immunology What is the immune system? Biological mechanism for identifying and destroying pathogens within a larger organism. Pathogens: agents that cause disease Bacteria,
CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS
CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS See APPENDIX (1) THE PRECIPITIN CURVE; (2) LABELING OF ANTIBODIES The defining characteristic of HUMORAL immune responses (which distinguishes them from CELL-MEDIATED
Principles of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
Elabscience Biotechnology Co.,Ltd
Biotechnology Co.,Ltd Your one-stop custom antibody service Antibody is a kind of protein that is the most widely used in the fields of biology and medicine. Antibodies, as the preparations for disease
POLYCLONAL ANTIBODY DEVELOPMENT
POLYCLONAL ANTIBODY DEVELOPMENT Abcore is committed to excellence, and to responding to the changing needs of our customers. We have developed polyclonal antibodies for biotechnology and pharmaceutical
Custom Antibody Services
Custom Antibody Services Custom service offerings DNA sequence Plasmid Peptide Structure Protein Peptide Small molecule Cells Spleen Lymphocytes Antigen Preparation Immunization Fusion & Subcloning Expansion
From Biology to Discovery
POLYCLONAL ANTIBODY PRODUCTION SERVICES Abbiotec offers custom polyclonal antibody production services to the scientific community to accelerate a project From Biology to Discovery. When the antibody for
Exclusive customized epigenetic antibodies
Exclusive customized epigenetic antibodies For many years, Diagenode has acquired a strong and reliable experience in the production of custom epigenetic antibodies, allowing us to become one of the most
Custom polyclonal antibody production
EUROGENTEC 2008 Catalogue > www.eurogentec.com > [email protected] Custom polyclonal antibody production 231 General overview 232 Selecting a polyclonal programme 233 Peptide antibodies versus protein
Questions related to peptide antibodies
www.lifetechindia.com Some Commonly Asked Questions about custom antibody production (Click over the Q# to see details) Questions related to protein antigens and general information Q1 How much antigen
Analysis of the adaptive immune response to West Nile virus
Analysis of the adaptive immune response to West Nile virus Jonathan Bramson (PI) Robin Parsons Alina Lelic Galina Denisova Lesley Latham Carole Evelegh Dmitri Denisov Strategy for characterizing T cell
Guidance for Industry
Guidance for Industry Interpreting Sameness of Monoclonal Antibody Products Under the Orphan Drug Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
Dr. Rita P.-Y. Chen Institute of Biological Chemistry Academia Sinica
PEPTIDE SYNTHESIS Dr. Rita P.-Y. Chen Institute of Biological Chemistry Academia Sinica 1 Solution phase chemistry -Time consuming: isolation and purification at each step -Low yield: can t drive reaction
B Cells and Antibodies
B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production
1.Gene Synthesis. 2.Peptide & Phospho-P. Assembly PCR. Design & Synthesis. Advantages. Specifications. Advantages
1.Gene Synthesis Assembly PCR Looking for a cdna for your research but could not fish out the gene through traditional cloning methods or a supplier? Abnova provides a gene synthesis service via assembly
B Cell Generation, Activation & Differentiation. B cell maturation
B Cell Generation, Activation & Differentiation Naïve B cells- have not encountered Ag. Have IgM and IgD on cell surface : have same binding VDJ regions but different constant region leaves bone marrow
The Use of Antibodies in Immunoassays
TECHNICAL NOTE The Use of Antibodies in Immunoassays Introduction Structure of an IgG Antibody Immunological reagents are the backbone of every immunoassay system. Immunoassays can be utilized to quantitatively
ELITE Custom Antibody Services
ELITE Custom Antibody Services ELITE Custom Antibody Services Experience, confidence, and understanding As a manufacturer and service provider, we have the experience, confidence, and understanding to
Activation and effector functions of HMI
Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ
OBTAINING MONOCLONAL ANTIBODIES TO EPITOPES OF IVERMECTIN
С.Сейфуллин атындағы Қазақ агротехникалық университетінің Ғылым жаршысы / Вестник науки Казахского агротехнического университета им. С. Сейфуллина. 2013. - 4 (79). C.8-14 OBTAINING MONOCLONAL ANTIBODIES
Hapten - a small molecule that is antigenic but not (by itself) immunogenic.
Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:
Antibody Production Price List
Antibody Production Price List Presenting Insight Biotechnology s price list for custom polyclonal and monoclonal antibody production services. We are happy to tailor individual packages towards the specific
Interim Progress Report R&D Project 348. Development of a Field Test Kit for Detection of Blue-Green Algal Toxins
Interim Progress Report R&D Project 348 Development of a Field Test Kit for Detection of Blue-Green Algal Toxins Biocode Limited November 1992 R&D 348/04/A ENVIRONMENT AGENCY 135357 CONTENTS SUMMARY KEYWORDS
Principles of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
Antibody Function & Structure
Antibody Function & Structure Specifically bind to antigens in both the recognition phase (cellular receptors) and during the effector phase (synthesis and secretion) of humoral immunity Serology: the
RSV F Recombinant Nanoparticle Vaccine: Summary of Clinical Data
RSV F Recombinant Nanoparticle Vaccine: Summary of Clinical Data Gregory M. Glenn M.D., SVP R&D Project Lead for RSV 9 th International Respiratory Syncytial Virus Symposium Cape Town, South Africa November
MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères 91030 Evry Cedex. www.mabsolut.com. is involved at each stage of your project
Mabsolus-2015-UK:Mise en page 1 03/07/15 14:13 Page1 Services provider Department of MABSolys from conception to validation MAB Solut is involved at each stage of your project Creation of antibodies Production
ELISA BIO 110 Lab 1. Immunity and Disease
ELISA BIO 110 Lab 1 Immunity and Disease Introduction The principal role of the mammalian immune response is to contain infectious disease agents. This response is mediated by several cellular and molecular
ABBOMAX, INC. Custom Services Polyclonal antibody production. www.abbomax.com. Monoclonal antibody production. Phosphospecific antibody production
ABBOMAX, INC Custom Services Polyclonal antibody production Monoclonal antibody production Phosphospecific antibody production Antibody purification and labeling Custom assay development Recombinant protein
Core Topic 2. The immune system and how vaccines work
Core Topic 2 The immune system and how vaccines work Learning outcome To be able to describe in outline the immune system and how vaccines work in individuals and populations Learning objectives Explain
Chapter 3. Immunity and how vaccines work
Chapter 3 Immunity and how vaccines work 3.1 Objectives: To understand and describe the immune system and how vaccines produce immunity To understand the differences between Passive and Active immunity
Modelling and analysis of T-cell epitope screening data.
Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,
Immunity and how vaccines work
1 Introduction Immunity is the ability of the human body to protect itself from infectious disease. The defence mechanisms of the body are complex and include innate (non-specific, non-adaptive) mechanisms
Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms
Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms Introduction Why does immunity to malaria take so long to develop? The parasite s survival depends on its
Geniron. Custom Antibody Services. Serum services Antibody Monoclonal. Purification Antibody Mono Y Genetic Immunization Genbody Polyclonal Antibody
Geniron Custom Antibody Services Serum services Antibody Monoclonal Purification Antibody Mono Y Genetic Immunization Genbody Polyclonal Antibody Geniron Poly Y WE PROVIDE OUR SERVICES TO With Expertise
Grundlagen und Anwendung der Genom- und Proteomforschung
Grundlagen und Anwendung der Genom- und Proteomforschung Profilmodul (Vorlesung/Seminar WS 2012/13) Philipps-Universität Marburg Fachbereich Biologie Professor Dr. Egon Amann & Dr. Frank Vitzthum Gastbeiträge
Chapter 2 Antibodies. Contents. Introduction
Chapter 2 Antibodies Keywords Immunohistochemistry Antibody labeling Fluorescence microscopy Fluorescent immunocytochemistry Fluorescent immunohistochemistry Indirect immunocytochemistry Immunostaining
The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small
The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small molecules that can elicit an immune response when linked
Microbiology AN INTRODUCTION EIGHTH EDITION
TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein
Non Specific Binding (NSB) in Antigen-Antibody Assays
Non Specific Binding (NSB) in Antigen-Antibody Assays Chem 395 Spring 2007 Instructor : Dr. James Rusling Presenter : Bhaskara V. Chikkaveeraiah OUTLINE Immunoassays Introduction Factors contributing to
HuCAL Custom Monoclonal Antibodies
HuCAL Custom Monoclonal HuCAL Custom Monoclonal Antibodies Highly Specific, Recombinant Antibodies in 8 Weeks Highly Specific Monoclonal Antibodies in Just 8 Weeks HuCAL PLATINUM (Human Combinatorial Antibody
From cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering
From cells to therapeuticsvivalis Humalex Fully human antibody discovery platform An integrated therapeutic development offering Humalex from bench-top to clinical development The Humalex platform enables
SCANTIBODIES Laboratory, Inc. Contract Monoclonal Antibody Production
A Technical Publication of SCANTIBODIES Laboratory, Inc. Volume 1 Number 4 9336 Abraham Way Santee, CA 92071 USA (619) 258-9300 fax (619) 258-9366 www.scantibodies.com SCANTIBODIES Laboratory, Inc. Contract
Algorithm for detecting Zika virus (ZIKV) 1
Algorithm for detecting Zika virus (ZIKV) 1 This algorithm is addressed to laboratories with established capacity (molecular, antigenic and/or serological) to detect dengue (DENV), Zika (ZIKV) 2, and chikungunya
The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015
The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response
B cell activation and Humoral Immunity
B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins.
THE His Tag Antibody, mab, Mouse
THE His Tag Antibody, mab, Mouse Cat. No. A00186 Technical Manual No. TM0243 Update date 01052011 I Description.... 1 II Key Features. 2 III Storage 2 IV Applications.... 2 V Examples - ELISA..... 2 VI
TABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.
x TABLE OF CONTENT ACKNOWLEDGEMENTS ENGLISH ABSTRACT THAI ABSTRACT LIST OF TABLES LIST OF FIGURES ABBREVIATIONS iii iv vii xv xvi xviii CHAPTER I: INTRODUCTION 1.1 Statement of problems 1 1.2 Literature
CHAPTER 6 ANTIBODY GENETICS: ISOTYPES, ALLOTYPES, IDIOTYPES
CHAPTER 6 ANTIBODY GENETICS: ISOTYPES, ALLOTYPES, IDIOTYPES See APPENDIX: (3) OUCHTERLONY; (4) AFFINITY CHROMATOGRAPHY Human immunoglobulins are made up of LIGHT and HEAVY chains encoded by a total of
New HLA class I epitopes defined by murine monoclonal antibodies
Human Immunology 71 (2010) 456 461 Contents lists available at ScienceDirect New HLA class I epitopes defined by murine monoclonal antibodies Nadim El-Awar a, *, Paul I. Terasaki b, Anh Nguyen a, Mamie
PRODUCTION AND CHARACTERIZATION OF ANTIBODIES AGAINST CROSSLINKED GELATIN NANOPARTICLES AND THEIR USE FOR ELISA SCREENING KIT DEVELOPMENT
PRODUCTION AND CHARACTERIZATION OF ANTIBODIES AGAINST CROSSLINKED GELATIN NANOPARTICLES AND THEIR USE FOR ELISA SCREENING KIT DEVELOPMENT DELAHAUT Philippe, DEHALU Vincent - CER Groupe, Belgium WEIGEL
Objectives. Immunologic Methods. Objectives. Immunology vs. Serology. Cross Reactivity. Sensitivity and Specificity. Definitions
Immunologic Methods Part One Definitions Part Two Antigen-Antibody Reactions CLS 420 Clinical Immunology and Molecular Diagnostics Kathy Trudell MLS (ASCP) CM SBB CM [email protected] Discuss the
Reconsideration Code 86386. Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative
Calendar Year 2013 Centers for Medicare and Medicaid Services (CMS) New and Reconsidered Clinical Laboratory Fee Schedule (CLFS) Test Codes And Final Payment Determinations Reconsideration Code 86386 Reconsideration
The Body s Defenses CHAPTER 24
CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,
Chapter 6: Antigen-Antibody Interactions
Chapter 6: Antigen-Antibody Interactions I. Strength of Ag-Ab interactions A. Antibody Affinity - strength of total noncovalent interactions between single Ag-binding site on an Ab and a single epitope
Antibody Services from GenScript
Services from GenScript www.genscript.com GenScript USA Inc. 860 Centennial Ave., Piscataway, NJ 08854 USA Toll-Free: 1-877-436-7274 Fax: 1-732-210-0262 1-732-885-5878 Academic Services Pharmaceutical
GenScript Antibody Services
GenScript Antibody Services Scientific experts, innovative technologies, proven performance We specialize in custom antibody production to empower your research Custom Polyclonal Antibody Production Custom
Custom Antibodies & Recombinant Proteins
Custom Antibodies & Recombinant Proteins INTRODUCTION Custom services to meet your research and development requirements Improvements in health, medicine and diagnostics over the past century can be largely
Some terms: An antigen is a molecule or pathogen capable of eliciting an immune response
Overview of the immune system We continue our discussion of protein structure by considering the structure of antibodies. All organisms are continually subject to attack by microorganisms and viruses.
Applications of Ab Molecules. Chapter 4 Monoclonal Ab (p.99) Chapter 5 Ab genes and Ab Engineering (p.128)
Applications of Ab Molecules Chapter 4 Monoclonal Ab (p.99) Chapter 5 Ab genes and Ab Engineering (p.128) Monoclonal Antibodies Clonal Selection of B Lymphocytes Hybridoma Köhler and Milsten (1975) - continuous
竞 争 性 分 析 Epitope Mapping 实 验 方 法
竞 争 性 分 析 Epitope Mapping 实 验 方 法 ABSTRACT The simplest way to determine whether two monoclonal antibodies bind to distinct sites on a protein antigen is to carry out a competition assay. The assay can
LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
STUDENT GUIDE LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) GOAL The goal of this laboratory lesson is to explain the concepts and technique of enzyme linked immunosorbent assay (ELISA). OBJECTIVES
Antibody Services from GenScript, Brochure
Services from GenScript, Brochure Interest in any of the products, request or order them at Bio-Connect. Bio-Connect B.V. T NL +31 (0)26 326 44 50 T BE +32 (0)2 503 03 48 Begonialaan 3a F NL +31 (0)26
HuCAL Custom Monoclonal Antibodies
HuCAL Custom Monoclonal Antibodies Highly Specific Monoclonal Antibodies in just 8 Weeks PROVEN, HIGHLY SPECIFIC, HIGH AFFINITY ANTIBODIES IN 8 WEEKS WITHOUT HuCAL PLATINUM IMMUNIZATION (Human Combinatorial
Making the switch to a safer CAR-T cell therapy
Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction
PepSets TM and their Applications
PepSets TM and their Applications PepSets peptide libraries are the rapid and cost effective solution for an immense range of bioactivity screening purposes Introduction to PepSets Peptide libraries are
PperCHIP. High-Content Peptide Microarrays. Epitope Mapping & Serum Profiling Services
PepperChip High-Content Peptide Microarrays PepperMap Epitope Mapping & Serum Profiling Services PperCHIP access to custom and dard peptide microarrays up to 9,000 features per in a uniquely flexible and
LANCE Eu-labeled antibodies for serine/threonine kinase assays
AD0078P-1 (en) 1 LANCE Eu-labeled antibodies for serine/threonine kinase assays For Research Use Only These instructions for use apply to the following reagents: AD0094 LANCE Eu-W1024 phospho-threonine
VETERINARY SERVICES MEMORANDUM NO. 800.90
August 5, 1998 VETERINARY SERVICES MEMORANDUM NO. 800.90 Subject: To: Guidelines for Veterinary Biological Relative Potency Assays and Reference Preparations Based on ELISA Antigen Quantification Veterinary
OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~
g944202 潘 怡 心 OKT3 ~ The first mouse monoclonal antibody used in clinical practice in the field of transplantation ~ As everybody knows, OKT3 is the first mouse monoclonal antibody produced for the treatment
Custom Antibody Services
prosci-inc.com Custom Antibody Services High Performance Antibodies and More Broad Antibody Catalog Extensive Antibody Services CUSTOM ANTIBODY SERVICES Established in 1998, ProSci Incorporated is a leading
Chapter 3.2» Custom Monoclonal
198 3 3.2 Custom Monoclonal 199 Mouse monoclonal antibody development Chapter 3.2» Custom Monoclonal 200 In vitro monoclonals expression service 201 Mouse monoclonal antibody additional services 202 Magnetic
